Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Alkem Laboratories Limited (NSE: ALKEM), ISIN INE540L01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ALKEM last traded at ₹5417.50 (+1.61%), with a 52-week range of ₹5052.05 to ₹5933.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 49.70%, FIIs 10.42%, DIIs 22.63%, mutual funds 16.71%.
EquiSense Score (ECS): 68/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.